Clinical characteristics, treatment characteristics, and endpoints assessed in real-world clinical practice of talazoparib in patients with HER2-negative BRCA-associated breast cancerAuthor:Huyvanyuk O.A. Т. 13, № 2 (50)
The choice of adjuvant treatment of endometrial cancer III A-C stagesAuthors: Dyakiv I.B. Kryzhanivska A.E. Ryzhyk V.M. Sokolovska M.V.... Т. 13, № 2 (50)
Neck lymph node metastasis from unknown primary lesionAuthors: Halay O.O. Bilynskyi B.T. Bondarenko S.G. Duda O.R.... Т. 13, № 2 (50)
How to select the most valuable anticancer drugs for reimbursement? Experience of ESMO and WHOAuthor:Poliakova D. Т. 13, № 1 (49)
The role of T790M mutation in first- and second-line therapy of patients with EGFR-positive non-small cell lung cancerAuthors: Storozhenko S.A. Shparyk Ya.V. Т. 13, № 1 (49)
Hepatocellular carcinoma: epidemiology, diagnostic, treatmentAuthors: Lukashenko A. Patsko V. Ostapenko Y. Cherchenko K. Т. 13, № 1 (49)
Assessment of overall survival obtained from the real-world study of using the combination of palbociclib with aromatase inhibitors as a first-line treatment of HR+/HER2− metastatic breast cancer
Metastatic bone lesions: molecular mechanisms as new avenues of therapeutic influence. Literature reviewAuthors: Solodyannуkova O.I. Bankovska N.V. Shypko A.F. Danylenko V.V.... Т. 13, № 1 (49)
Pancreatic Cancer: Innovations For Life
ESPEN practical guideline: сlinical nutrition in cancerAuthors: Muscaritoli Maurizio Arends Jann Bachmann Patrick Baracos Vickie ... Т. 13, № 1 (49)
Transabdominal ultrasound colonography in the diagnosis of colon polypsAuthors: Shcherbina O.V. Koval O.V. Zhaivoronok M.M. Т. 13, № 1 (49)
Intra-arterial chemotherapy in metastatic colorectal cancer: a review of the literature and a clinical caseAuthors: Cherchenko K. Lukashenko A. Ostapenko Y. Patsko V.... Т. 13, № 1 (49)
Surgery of inflammatory breast cancerAuthors: Smolanka I.I. Movchan O.V. Lyashenko A.O. Т. 13, № 1 (49)
Ki-67 expression rates as indicator of metastatic lesions in lung neuroendocrine neoplasmsAuthor:Chytaieva H. Т. 12, № 3-4 (47-48)
Oncourology. The latest technologies in today’s realities: the results of the PROfound study — the efficacy and safety profile of olaparib in mCRPCТ. 12, № 3-4 (47-48)
